Abstract
Gestational carrier is increasingly used as a treatment option for infertile women who do not have a uterus, who have a history of poor pregnancy outcomes, who are advised not to carry a pregnancy, or for same sex couples or for single men. Numerous medical, ethical, legal, and social issues are involved in gestational carrier cycles, particularly in instances when the commissioning couple and the carrier live in different countries and when use of donor gametes is also involved. Treatment involves appropriate counseling of all concerned parties regarding the entire process, including their rights, duties, and potential complications, thorough medical screening, signing of all consent forms, ensuring legal compliance, signing of detailed contracts between the parties, ovarian stimulation of the genetic mother, medical preparation of the carrier, ovulation induction, oocyte retrieval and embryo transfer, care of the carrier during pregnancy and at delivery, and handing over the child after birth with genetic finger printing if desired.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Old Testament, Book of Genesis 16:2, KJV.
Old Testament, Book of Genesis 30:3, KJV.
Ber R. Theoretical Medicine and Bioethics. Ethical Issues in Gestational Surrogacy. Theor Med Bioeth. 2000;21:153–69.
Jones HW, Cooke I, Kempers R, Brinsden P, Saunders D. International Federation of Fertility Societies Surveillance 2010: preface. Fertil Steril. 2010;95:491–6.
Ethics Committee of the American Society for Reproductive Medicine. Access to fertility treatment by gays, lesbians, and unmarried persons. Fertil Steril. 2009;92:1190–3.
Shenfield G, Pennings G, Cohen J, Devroey P, de Wert G, Tarlatzis B. ESHRE Task Force on Ethics and Law. Hum Reprod. 2005;20:2705–7.
Indian Council of Medical Research. National Guidelines for Accreditation, Supervision and Regulation of ART Clinics in India. Code of practice and ethical considerations and legal issues. New Delhi, India. National Academy of Medical Sciences (India). 2005, 68-69.
Indian Council of Medical Research. The Assisted Reproductive Technologies (Regulation) Bill. 2010;25–29.
Cotton K. Surrogacy should pay Br Med J. 2000;320:928–9.
Tieu MM. Altruistic surrogacy: the necessary objectification of surrogate mothers. J Med Ethics. 2009;35:171–5.
Practice Guideline, Recommendations for practices using gestational carriers. (https://www.asrm.org/uploadedFiles/ASRM_Content/News_and_Publications/Practice_Guidelines/Committee_Opinions/recommendations_for_practices_utilizing_gestational_carriers_nonmembers.pdf
Boivin J, Appleton TC, Baetens P, Baron J, Bitzer J, Corrigan E, et al. Guidelines for counseling in infertility: outline version. Hum Reprod. 2001;16:1301–4.
Van Den Ekker OB. Psychosocial aspects of surrogate motherhood. Hum Reprod Update. 2007;13:53–62.
Parliament by the Secretary of State for Health. Donor recruitment, assessment and screening; Surrogacy. Code of Practice for clinics licensed by the Human Fertilisation and Embryology Authority, 8th Edition. London 2011.
Jadva V, Murray C, Lycett E, MacCallum F, Golombok S. Surrogacy: the experiences of surrogate mothers. Hum Reprod. 2003;18:2196–204.
MacCallum F, Lycett E, Murray C, Jadva V, Golombok S. Surrogacy: the experience of commissioning couples. Hum Reprod. 2003;18:1334–42.
Schenker JG. Assisted reproduction practice in Europe: legal and ethical aspects. Hum Reprod. 1997;3:173–84.
Utian WH, Sheean L, Goldfarb JM, Kiwi R. Successful pregnancy after in vitro fertilization and embryo transfer from an infertile woman to a surrogate. N Engl J Med. 1985;313:1351.
Utian WH, Goldfarb JM, Kiwi R, et al. Preliminary experience with in vitro fertilization-surrogate gestational pregnancy. Fertil Steril. 1989;52:633.
Steptoe P. Surrogacy. Br Med J (Clin Res Edn). 1987;294:1688–9.
Beski S, Gorgy A, Venkat G, et al. Gestational surrogacy: a feasible option for patients with Rokitansky syndrome. Hum Reprod. 2000;15:2326.
Corson SL, Kelly M, Braverman AM, English ME. Gestational carrier pregnancy. Fertil Steril. 1998;69:670–4.
Brinsden PR, Appleton TC, Murray E, et al. Treatment by in vitro fertilisation with surrogacy: experience of one British centre. BMJ. 2000;320:924.
Raziel A, Schachter M, Strassburger D, et al. Eight years’ experience with an IVF surrogate gestational pregnancy programme. Reprod Biomed Online. 2005;11:254.
Meniru GI, Craft I. Assisted conception options for patients with good-prognosis cervical cancer. Lancet. 1997;349:542.
Gibbons WE, Cedars M, Ness RB. Society for Assisted Reproductive Technologies Writing Group. Toward understanding obstetrical outcome in advanced assisted reproduction: varying sperm, oocyte, and uterine source and diagnosis. Fertil Steril. 2011;95:1645.
Parkinson J, Tran C, Tan T, Nelson J, Batzofin J, Serafini P. Perinatal outcome after in-vitro fertilization-surrogacy. Hum Reprod. 1999;14(3):671–6.
Goldfarb JM, Austin C, Peskin B, et al. Fifteen years experience with an in-vitro fertilization surrogate gestational pregnancy programme. Hum Reprod. 2000;15:1075.
https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Appendix 1
Appendix 2
Date of filling the form (except items 20–31) | ||
Date of filling items 20–31 | ||
Basic information: | History: | Investigations |
1.Identification number | 12.Obstetric history : | 20.Blood group and Rh status |
2.Name | a. Number of deliveries | 21.Complete blood picture |
3.Age/Date of birth | b. Number of abortions | a.Hb |
4.Address | c. Other points of note | b.Total RBC count |
5.Photograph | 13.Menstrual history | c.Total WBC count |
6.Tel no. | 14.History of use of contraceptives | d.Differential WBC count |
7.Marital status | 15.Medical history | e.Platelet count |
8.Education : | 16.Family history | f.Peripheral smear |
a.Surrogate | 17.Has she acted as surrogate earlier : Yes No | 22.Random blood sugar |
b.Spouse | If so, how many times did it lead to a successful pregnancy? | 23.Blood urea/Serum creatinine |
9.Occupation : | 18.History of blood transfusion | 24.SGPT |
a.Surrogate | 19.History of substance abuse | 25.Routine urine examination |
b.Spouse | 26.HBsAg status | |
10.Monthly Income | 27.Hepatitis C status | |
11.Religion | 28.HIV status | |
29.Hemoglobin A2 (for thallasemia) status | ||
30.HIV PCR | ||
a.Surrogate | ||
b.Spouse | ||
31.Any other specific test | ||
Footnotes | FEATURES: | |
(1) To be carried out within 15 days prior to embryo transfer. Test no.30 to be done only if test 28 is negative | 32.Height | |
33.Weight | ||
(2) Any additional test carried out on the basis of the history and examination of the surrogate OR any test requested by the recipient who shall pay for the additional requested test | Detailed physical examination: | |
34.Pulse | ||
35.Blood pressure | ||
36.Temperature | ||
To the patient, a copy of this form without items 20–31 filled in, may be provided when asked for. The investigations in items 20–31 may be done when the patient has chosen the surrogate provisionally, subject to the results of tests in items 20–31 being satisfactory | 37.Respiratory system | |
38.Cardiovascular system | ||
39.Per abdominal examination | ||
40.Per speculum examination | ||
41.Per vaginal examination | ||
Name(s) and signature(s) with date(s) of person(s) filling the form: | 42.Trans-vaginal sonography | |
43.Other systems |
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Patel, P., Banker, M. (2012). Gestational Carrier. In: Ginsburg, E., Racowsky, C. (eds) In Vitro Fertilization. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9848-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9848-4_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9847-7
Online ISBN: 978-1-4419-9848-4
eBook Packages: MedicineMedicine (R0)